Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Alzheimer's Disease
Recent news which mentions Alzheimer's Disease
< Previous
1
2
3
Next >
Medicare details plan to cover Alzheimer's treatments
June 01, 2023
Tags
US Economy
World News
Health & Science
From
CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
May 12, 2023
Tags
Biogen Inc
Breaking News: Business
Health care industry
From
CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
May 03, 2023
Tags
Biotech and Pharmaceuticals
Policy
Eli Lilly and Co
From
CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
May 03, 2023
Tags
Science
Biotech and Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Biogen Inc
Breaking News: Business
Alzheimer's disease
From
CNBC.com News
March 2023 Miscellany
March 27, 2023
Tags
Doc Gumshoe
Prostate Cancer
lung cancer
From
Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
January 17, 2023
Tags
Doc Gumshoe
Parkinson's Disease
Cassava Sciences (SAVA)
From
Stock Gumshoe
Relevant Updates – December 2022
December 27, 2022
Tags
Eisai (ESALY)
Moderna Therapeutics (MRNA)
influenza
From
Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
November 14, 2022
Tickers
MOR
RHHBF
RHHBY
RHHVF
Tags
General
Movers
Large Cap
From
Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
November 13, 2022
Tags
Lifestyle
Smoking
Nutrition
From
CNBC.com News
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
November 07, 2022
Tickers
SPRC
Tags
SciSparc Ltd/
Market News
Benzinga
From
Benzinga
Odd & Ends – October 2022
October 27, 2022
Tags
Eli Lilly (LLY)
Doc Gumshoe
Roche (RHHBF RHHBY)
From
Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
Tickers
ABOS
ACIU
ALZN
ANVS
Tags
PRTA
RHHBY
LLY
From
Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
Tickers
BIIB
ESALY
Tags
BIIB
Aduhelm
ESALY
From
Benzinga
Following Up on Your Suggestions – September 2022
September 26, 2022
Tickers
DIET
Tags
Pfizer (PFE)
H/ Lundbeck (HLBBF HLUBF)
vitamins
From
Stock Gumshoe
Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon
August 10, 2022
Tickers
DGX
Tags
NYSE:DGX
Alzheimer's Disease
Quest Diagnostics
From
3BL Media: Corporate Social Responsibility, Energy and Health News
EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
August 04, 2022
Tickers
CGTX
Tags
Market News
Exclusives
News
From
Benzinga
Alzheimer’s Drug Development — July Responses to Questions & Requests
July 19, 2022
Tags
Dundee Corp (DC/A/TO DDEJF)
TauRX Pharmaceuticals
Cassava Sciences (SAVA)
From
Stock Gumshoe
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
July 08, 2022
Tickers
ABBV
ALEC
Tags
Market News
News
Health Care
From
Benzinga
Alzheimer’s Disease June 2022 – Possible Signs of Progress
June 13, 2022
Tags
Alzheimer's Disease
TauRX Pharmaceuticals
Guest Articles
From
Stock Gumshoe
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
May 23, 2022
Tickers
BIIB
Tags
General
News
Alzheimer's disease
From
Benzinga
Alzheimer’s Disease May 2022 – Is There Anything New?
May 10, 2022
Tags
inflammation
Eisai (ESALY)
BACE Inhibitors
From
Stock Gumshoe
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
May 10, 2022
Tickers
BIIB
ESALF
ESALY
Tags
ESALY
BIIB
Briefs
From
Benzinga
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
April 19, 2022
Tickers
SAVA
Tags
Small Cap
Market News
Biotech
From
Benzinga
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
April 13, 2022
Tickers
LGVN
Tags
Market News
Exclusives
LGVN
From
Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
April 08, 2022
Tickers
BIIB
Tags
Benzinga
Biotech
Alzheimer's disease
From
Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
March 31, 2022
Tickers
LGVN
Tags
Phase 1 Trial
General
Biotech
From
Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
March 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Biotech
Benzinga
Health Care
From
Benzinga
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
March 16, 2022
Tickers
BIIB
Tags
Phase 3 Trial
General
Market News
From
Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
March 16, 2022
Tickers
PRTA
Tags
PRTA
Parkinson’s Disease
General
From
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.